Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01138592 · ClinicalTrials.gov registry record
Pilot Study to Evaluate the Clinical Utility of Auscultation Software at Remote Locations
A clinical trial, sponsored by Solventum US.
- Completed
- Registry status
- 150
- Enrollment target
NCT01138592: Completed study, sponsored by Solventum US.
NCT01138592 is a clinical trial that has completed, run by Solventum US. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01138592 has completed, sponsored by Solventum US.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
Primary Objective: Evaluation of the utility of real-time, scope-to-scope communication between commercially-available 3M Littmann Electronic Model 3200 Electronic stethoscopes over a dedicated intranet system for the assessment of patients at remote (satellite) clinic locations by centrally-located (hub) medical providers. Secondary Objective: Comparison of the accuracy of patient assessment between the remotely located, mid-level presenter with the centrally-located physician or nurse practitioner provider.
Primary Outcome
Presence or absence of heart or lung sound; e.g., murmurs, etc., and/or rales, rhonchii, wheezes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-01 |
What the finished NCT01138592 record still lists
NCT01138592 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01138592 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01138592 about?
NCT01138592 is a clinical study titled "Pilot Study to Evaluate the Clinical Utility of Auscultation Software at Remote Locations". Primary Objective: Evaluation of the utility of real-time, scope-to-scope communication between commercially-available 3M Littmann Electronic Model 3200 Electronic stethoscopes over a dedicated intranet system for the assessment of patients at remote (satellite) clinic locations by centrally-located...
What is the current status of trial NCT01138592?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2010-06. Estimated completion is 2011-01.
Who is sponsoring clinical trial NCT01138592?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia